TrialAntimicrobial agents and chemotherapy2013

Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.

Julio Ramirez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.